Guru Ownership Trend
Guru Analysis for Supernus Pharmaceuticals, Inc. (SUPN)
Supernus Pharmaceuticals, Inc. (SUPN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $170.63 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bearish. This is evidenced by a $53.29 M net outflow during the quarter.
Recent activity highlights Robert Bruce who increased their stake by 21.8%. Conversely, Steven Cohen reduced exposure by 41.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Supernus Pharmaceuticals, Inc. (SUPN)
Major holders include Renaissance Technologies (RenTech) ($88.14 M), Steven Cohen ($68.16 M), Chuck Royce ($11.89 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.45 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $53.29 M, with 2 managers increasing positions and 6 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 3 fully exited SUPN. The total reported sell value was $55.88 M.
Yes, 0 managers opened new positions in SUPN, and 2 increased their existing holdings. The total reported buy value was $2.59 M.